Sagimet Biosciences Inc.(SGMT)

$10.55—Stale · unknown old

Chart

Sagimet Biosciences Inc.(SGMT)

NASDAQ • Last print unknown ago

$10.55—Stale · unknown old

Chart Studio

SGMT(SGMT)

SGMT

Overview Fair Value Stream Notebook Intel Chart History Fundamentals TTM Earnings Analysts News Financials Insiders Institl.DCF Peers

Q4 2026 EPS Estimate

$-0.25

Nov 12, 2026 · Reports before open

Revenue Estimate

$166,667

FY2030E EPS$0.80

Analyst Sentiment

Wall St. Consensus

Buy

7 analysts·Limited coverage

Score

6 Buy (86%)1 Hold (14%)0 Sell (0%)

Rating Breakdown

Strong Buy

00%

Buy

686%

Hold

114%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Bear

$6.00

-43.1%

Consensus

$7.00

-33.6%

Bull

$8.00

-24.2%

12-Month Target Range7 analysts

$6.00$7.00$8.00

Current $10.55Consensus

Current Price

$10.55

Above Consensus

$3.55

Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

Forward Growth Estimates (YoY)

FY2027

Rev+6673.86%

EPS—

FY2028

Rev+223.95%

EPS—

FY2029

Rev+399.95%

EPS—

Raw consensus estimates (low / average / high) from covering analysts.

Annual

Metric	FY2026E	FY2027E	FY2028E	FY2029E	FY2030E
Revenue Avg	$111,111	$8M	$24M	$122M	$301M
Low	$111,111	$8M	$24M	$122M	$301M
High	$111,111	$8M	$24M	$122M	$301M
EBITDA Avg	$-38M	$-46M	$-58M	$-23M	$33M
Low	$-47M	$-68M	$-88M	$-23M	$33M
High	$-30M	$-23M	$-28M	$-23M	$33M
EBIT Avg	$-39M	$-46M	$-58M	$-23M	$33M
Low	$-47M	$-68M	$-88M	$-23M	$33M
High	$-30M	$-23M	$-28M	$-23M	$33M
Net Income Avg	$-39M	$-46M	$-58M	$-23M	$26M
Low	$-47M	$-68M	$-88M	$-23M	$26M
High	$-30M	$-23M	$-28M	$-23M	$26M
EPS Avg	$-1.17	$-1.39	$-1.68	$-0.71	$0.80
Low	$-1.44	$-2.10	$-2.73	$-0.71	$0.80
High	$-0.94	$-0.73	$-0.88	$-0.71	$0.80
Analysts (Rev / EPS)	6 / 7	6 / 7	8 / 8	6 / 5	6 / 5

Quarterly

Metric	Q3 2026	Q4 2026	Q1 2027	Q2 2027	Q3 2027	Q4 2027
Revenue Avg	$166,667	$166,667	$333,333	$333,333	$333,333	$333,333
Low	$166,667	$166,667	$333,333	$333,333	$333,333	$333,333
High	$166,667	$166,667	$333,333	$333,333	$333,333	$333,333
EBITDA Avg	$-7M	$-10M	$-12M	$-13M	$-15M	$-15M
Low	$-8M	$-11M	$-12M	$-13M	$-15M	$-15M
High	$-4M	$-5M	$-12M	$-13M	$-15M	$-15M
EBIT Avg	$-14M	$-16M	$-18M	$-19M	$-21M	$-20M
Low	$-15M	$-18M	$-18M	$-19M	$-21M	$-20M
High	$-11M	$-12M	$-18M	$-19M	$-21M	$-20M
Net Income Avg	$-14M	$-16M	$-18M	$-19M	$-21M	$-20M
Low	$-15M	$-18M	$-18M	$-19M	$-21M	$-20M
High	$-11M	$-12M	$-18M	$-19M	$-21M	$-20M
EPS Avg	$-0.26	$-0.30	$-0.33	$-0.36	$-0.39	$-0.37
Low	$-0.29	$-0.33	$-0.33	$-0.36	$-0.39	$-0.37
High	$-0.20	$-0.22	$-0.33	$-0.36	$-0.39	$-0.37
Analysts (Rev / EPS)	4 / 6	5 / 6	4 / 2	5 / 2	4 / 2	5 / 2

Earnings Surprises

Recent Analyst Actions

Jan 27, 2026Barclays

Sagimet Biosciences initiated with an Equal Weight at Barclays

Target:$8.00

+31.4%from $6.09

Jun 28, 2024Goldman Sachs

Sagimet Biosciences downgraded to Neutral from Buy at Goldman Sachs

Target:$6.00

+46.0%from $4.11

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance